UA94065C2 - Dihydropseudoerythromycin derivatives - Google Patents
Dihydropseudoerythromycin derivativesInfo
- Publication number
- UA94065C2 UA94065C2 UAA200806366A UAA200806366A UA94065C2 UA 94065 C2 UA94065 C2 UA 94065C2 UA A200806366 A UAA200806366 A UA A200806366A UA A200806366 A UAA200806366 A UA A200806366A UA 94065 C2 UA94065 C2 UA 94065C2
- Authority
- UA
- Ukraine
- Prior art keywords
- dihydropseudoerythromycin
- derivatives
- dihydropseudoerythromycin derivatives
- compounds
- salts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
Изобретение касается соединения, представленного формулой [I], где каждый радикал является таким, как определено в описании, или его фармацевтически приемлемой соли, а также фармацевтической композиции, которая содержит соединение как активный ингредиент.[I]
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005301070 | 2005-10-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
UA94065C2 true UA94065C2 (en) | 2011-04-11 |
Family
ID=37942921
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA200806366A UA94065C2 (en) | 2005-10-14 | 2006-10-13 | Dihydropseudoerythromycin derivatives |
Country Status (18)
Country | Link |
---|---|
US (1) | US8133871B2 (ru) |
EP (1) | EP1950219B1 (ru) |
JP (1) | JP5118973B2 (ru) |
KR (1) | KR101384927B1 (ru) |
CN (1) | CN101326192B (ru) |
AT (1) | ATE513842T1 (ru) |
AU (1) | AU2006300215B2 (ru) |
BR (1) | BRPI0617391A2 (ru) |
CA (1) | CA2625055C (ru) |
EA (1) | EA015737B1 (ru) |
ES (1) | ES2369898T3 (ru) |
IL (1) | IL190643A (ru) |
MY (1) | MY147211A (ru) |
NZ (1) | NZ567772A (ru) |
PL (1) | PL1950219T3 (ru) |
UA (1) | UA94065C2 (ru) |
WO (1) | WO2007043710A1 (ru) |
ZA (1) | ZA200803414B (ru) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7776314B2 (en) | 2002-06-17 | 2010-08-17 | Grunenthal Gmbh | Abuse-proofed dosage system |
DE10336400A1 (de) | 2003-08-06 | 2005-03-24 | Grünenthal GmbH | Gegen Missbrauch gesicherte Darreichungsform |
DE102005005446A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Bruchfeste Darreichungsformen mit retardierter Freisetzung |
DE10361596A1 (de) | 2003-12-24 | 2005-09-29 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
US20070048228A1 (en) | 2003-08-06 | 2007-03-01 | Elisabeth Arkenau-Maric | Abuse-proofed dosage form |
DE102004032049A1 (de) | 2004-07-01 | 2006-01-19 | Grünenthal GmbH | Gegen Missbrauch gesicherte, orale Darreichungsform |
DE102005005449A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
DE102007011485A1 (de) | 2007-03-07 | 2008-09-11 | Grünenthal GmbH | Darreichungsform mit erschwertem Missbrauch |
US8383152B2 (en) | 2008-01-25 | 2013-02-26 | Gruenenthal Gmbh | Pharmaceutical dosage form |
SI2273983T1 (sl) | 2008-05-09 | 2016-11-30 | Gruenenthal Gmbh | Postopek za pripravo intermediatne praškaste formulacije in končne trdne odmerne oblike z uporabo stopnje strjevanja z razprševanjem |
TW201105316A (en) | 2009-07-22 | 2011-02-16 | Gruenenthal Gmbh | Hot-melt extruded pharmaceutical dosage form |
AU2010275755B2 (en) | 2009-07-22 | 2014-04-24 | Grünenthal GmbH | Oxidation-stabilized tamper-resistant dosage form |
MX2013002377A (es) | 2010-09-02 | 2013-04-29 | Gruenenthal Gmbh | Forma de dosificacion resistente a manipulacion que comprende una sal inorganica. |
CN103179954A (zh) | 2010-09-02 | 2013-06-26 | 格吕伦塔尔有限公司 | 包含阴离子聚合物的抗破碎剂型 |
US10201502B2 (en) | 2011-07-29 | 2019-02-12 | Gruenenthal Gmbh | Tamper-resistant tablet providing immediate drug release |
RS56527B1 (sr) | 2011-07-29 | 2018-02-28 | Gruenenthal Gmbh | Tableta za trenutno oslobađanje leka rezistentna na zloupotrebu |
MX356421B (es) | 2012-02-28 | 2018-05-29 | Gruenenthal Gmbh | Forma de dosificacion resistente a la manipulacion indebida que comprende un compuesto farmacologicamente activo y un polimero anionico. |
EA201401139A1 (ru) | 2012-04-18 | 2015-03-31 | Грюненталь Гмбх | Устойчивая к разрушению и к сбросу дозы фармацевтическая лекарственная форма |
US10064945B2 (en) | 2012-05-11 | 2018-09-04 | Gruenenthal Gmbh | Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc |
BR112015026549A2 (pt) | 2013-05-29 | 2017-07-25 | Gruenenthal Gmbh | forma de dosagem à prova de violação contendo uma ou mais partículas |
CA2913209A1 (en) | 2013-05-29 | 2014-12-04 | Grunenthal Gmbh | Tamper resistant dosage form with bimodal release profile |
CA2917136C (en) | 2013-07-12 | 2022-05-31 | Grunenthal Gmbh | Tamper-resistant dosage form containing ethylene-vinyl acetate polymer |
WO2015078891A1 (en) | 2013-11-26 | 2015-06-04 | Farmaceutici Formenti S.P.A. | Preparation of a powdery pharmaceutical composition by means of cryo-milling |
WO2015173195A1 (en) | 2014-05-12 | 2015-11-19 | Grünenthal GmbH | Tamper resistant immediate release capsule formulation comprising tapentadol |
MX2016015417A (es) | 2014-05-26 | 2017-02-22 | Gruenenthal Gmbh | Multiparticulas protegidas contra vertido de dosis etanolico. |
CN107531737A (zh) * | 2015-03-25 | 2018-01-02 | 哈佛大学的校长及成员们 | 脱氧糖胺的合成 |
EP3285745A1 (en) | 2015-04-24 | 2018-02-28 | Grünenthal GmbH | Tamper-resistant dosage form with immediate release and resistance against solvent extraction |
JP2018526414A (ja) | 2015-09-10 | 2018-09-13 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 乱用抑止性の即放性製剤を用いた経口過剰摂取に対する保護 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5106961A (en) | 1987-05-26 | 1992-04-21 | Eli Lilly And Company | Erythromycin ring-contracted derivatives |
ATE321770T1 (de) | 2000-08-17 | 2006-04-15 | Kitasato Inst | Pseudoerythromycin-derivate |
CA2429709A1 (en) * | 2000-12-01 | 2002-07-04 | Gary Ashley | Motilide compounds |
US20020094962A1 (en) | 2000-12-01 | 2002-07-18 | Gary Ashley | Motilide compounds |
US20040067896A1 (en) | 2002-07-25 | 2004-04-08 | The Kitasato Institute | Novel pseudoerythromycin derivatives |
WO2004039823A1 (ja) * | 2002-10-29 | 2004-05-13 | The Kitasato Institute | 抗真菌活性増強作用を有する新規マクロライド誘導体 |
-
2006
- 2006-10-13 WO PCT/JP2006/320888 patent/WO2007043710A1/ja active Application Filing
- 2006-10-13 PL PL06821966T patent/PL1950219T3/pl unknown
- 2006-10-13 EA EA200801083A patent/EA015737B1/ru not_active IP Right Cessation
- 2006-10-13 JP JP2007540233A patent/JP5118973B2/ja not_active Expired - Fee Related
- 2006-10-13 BR BRPI0617391-8A patent/BRPI0617391A2/pt not_active Application Discontinuation
- 2006-10-13 UA UAA200806366A patent/UA94065C2/ru unknown
- 2006-10-13 ES ES06821966T patent/ES2369898T3/es active Active
- 2006-10-13 NZ NZ567772A patent/NZ567772A/en not_active IP Right Cessation
- 2006-10-13 AT AT06821966T patent/ATE513842T1/de active
- 2006-10-13 KR KR1020087011148A patent/KR101384927B1/ko not_active IP Right Cessation
- 2006-10-13 AU AU2006300215A patent/AU2006300215B2/en not_active Ceased
- 2006-10-13 CA CA2625055A patent/CA2625055C/en not_active Expired - Fee Related
- 2006-10-13 ZA ZA200803414A patent/ZA200803414B/xx unknown
- 2006-10-13 EP EP06821966A patent/EP1950219B1/en active Active
- 2006-10-13 CN CN2006800462555A patent/CN101326192B/zh not_active Expired - Fee Related
- 2006-10-13 US US12/083,484 patent/US8133871B2/en not_active Expired - Fee Related
-
2008
- 2008-04-06 IL IL190643A patent/IL190643A/en not_active IP Right Cessation
- 2008-04-09 MY MYPI20081033A patent/MY147211A/en unknown
Also Published As
Publication number | Publication date |
---|---|
US20090131341A1 (en) | 2009-05-21 |
US8133871B2 (en) | 2012-03-13 |
NZ567772A (en) | 2010-07-30 |
ZA200803414B (en) | 2009-09-30 |
PL1950219T3 (pl) | 2011-11-30 |
EP1950219A4 (en) | 2010-02-03 |
ATE513842T1 (de) | 2011-07-15 |
CN101326192B (zh) | 2012-06-20 |
AU2006300215A1 (en) | 2007-04-19 |
KR20080064861A (ko) | 2008-07-09 |
WO2007043710A9 (ja) | 2007-06-07 |
EA015737B1 (ru) | 2011-10-31 |
BRPI0617391A2 (pt) | 2011-07-26 |
MY147211A (en) | 2012-11-14 |
IL190643A0 (en) | 2008-11-03 |
CA2625055A1 (en) | 2007-04-19 |
ES2369898T3 (es) | 2011-12-07 |
IL190643A (en) | 2012-03-29 |
EP1950219B1 (en) | 2011-06-22 |
KR101384927B1 (ko) | 2014-04-11 |
CA2625055C (en) | 2013-12-24 |
EP1950219A1 (en) | 2008-07-30 |
EA200801083A1 (ru) | 2009-02-27 |
CN101326192A (zh) | 2008-12-17 |
JP5118973B2 (ja) | 2013-01-16 |
JPWO2007043710A1 (ja) | 2009-07-16 |
WO2007043710A1 (ja) | 2007-04-19 |
AU2006300215B2 (en) | 2012-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA94065C2 (en) | Dihydropseudoerythromycin derivatives | |
TW200642689A (en) | Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient | |
TW200744588A (en) | Pharmaceutical composition for external use | |
MX2007010072A (es) | Derivados de piperidina antibacterianos. | |
TW200633964A (en) | Tetralin and indane derivatives and uses thereof | |
RS51569B (en) | COMPOSITIONS CONTAINING CRYSTAL TRANS - (+/-) - DELTA-9-TETRAHYDROCANABINOL | |
TW200700393A (en) | Novel cis-2,4,5-triaryl-imidazolines | |
WO2007061360A3 (en) | Novel 3-bicyclocarbonylaminopyridine-2-carboxamides or 3-bicyclocarbonylaminopyrazine-2-carboxamides | |
MX2007003546A (es) | Derivados de indozolona como inhibidores de 11-beta- hidroxiesteroide-deshidrogenasa. | |
TNSN08407A1 (en) | Organic compounds | |
TW200626598A (en) | Pyrrazolo-pyrimidine derivatives | |
WO2008120725A1 (ja) | 新規ピロリノン誘導体およびそれを含有する医薬組成物 | |
SE0401971D0 (sv) | Piperidne derivatives | |
TW200716628A (en) | Novel compounds | |
UA96759C2 (en) | 2-ARYLINDOLE DERIVATIVES AS mPGES-I INHIBITORS | |
MX2009006334A (es) | Derivados de heteroaril-pirrolidinil- y -piperidinil-cetona. | |
WO2007099171A3 (en) | Bicyclo-pyrazoles active as kinase inhibitors | |
TW200730510A (en) | Chroman compounds | |
WO2007068728A3 (en) | N-substituted pyrrolopyridinones active as kinase inhibitors | |
MX2009003169A (es) | Derivados de sulfonamida. | |
TW200738697A (en) | Benzimidazole derivatives as 5-HT6,5-HT24 | |
WO2007018941A3 (en) | Pyrimidyl-thiophene derivatives | |
MX2007008585A (es) | Compuestos peptidicos. | |
WO2009075250A1 (ja) | 植物病害防除剤 | |
TW200626567A (en) | Benzoxazine and quinoxaline derivatives and uses |